Cetrorelix Acetate Kit
Product Images NDC 68083-600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 68083-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cetrorelix-spl-fig.1 (1)

Cetrorelix-spl-fig.1 (1)
FDA Label Image

10 (10)

10 (10)
FDA Label Image

Cetrorelix-spl-fig.11 (11)

Cetrorelix-spl-fig.11 (11)
FDA Label Image

Cetrorelix-spl-fig.2 (2)

Cetrorelix-spl-fig.2 (2)
FDA Label Image

Cetrorelix-spl-fig.3 (3)

Cetrorelix-spl-fig.3 (3)
FDA Label Image

Cetrorelix-spl-fig.4 (4)

Cetrorelix-spl-fig.4 (4)
FDA Label Image

Cetrorelix-spl-fig.5 (5)

Cetrorelix-spl-fig.5 (5)
FDA Label Image

Cetrorelix-spl-fig.6 (6)

Cetrorelix-spl-fig.6 (6)
FDA Label Image

Cetrorelix-spl-fig.7 (7)

Cetrorelix-spl-fig.7 (7)
FDA Label Image

Cetrorelix-spl-fig.8 (8)

Cetrorelix-spl-fig.8 (8)
FDA Label Image

Cetrorelix-spl-fig.9 (9)

Cetrorelix-spl-fig.9 (9)
FDA Label Image

Cetrorelix-spl-pfs-label (Pfs Label)

Cetrorelix-spl-pfs-label (Pfs Label)
This text provides information about a pharmaceutical product with NDC 68083-598-01, labeled for prescription use, containing 1 mL of Prefilled Sterile Water for Injection, USP. The product is manufactured by Gland Pharma Limited in Hyderabad, India. It includes the manufacturer's address and a manufacturing license number.*
FDA Label Image

Cetrorelix-spl-principle-carton (Principle Carton)

Cetrorelix-spl-principle-carton (Principle Carton)
This text provides detailed information about a medication called Cetrorelix Acetate for Injection. It includes details about the content of one vial and pre-filled syringe, storage instructions, dosage information, and safety precautions. The medication is intended for subcutaneous use only and should be stored refrigerated at 2-8°C (36-46°F). It also emphasizes the importance of reconstitution with the provided diluent and immediate use post-reconstitution. The text further mentions the availability of a packaged tray containing a lyophilized powder, pre-filled syringe with diluent, and needles for injection. Additionally, it provides the NDC number for the product and contact information for reporting side effects.*
FDA Label Image

Cetrorelix-spl-structure (Structure)

Cetrorelix-spl-structure (Structure)
FDA Label Image

Cetrorelix-spl-tray-label (Tray Label)

Cetrorelix-spl-tray-label (Tray Label)
This text provides details about Cetrorelix Acetate for Injection 0.25 mg/vial, including the contents of a single-dose vial with lyophilized powder for reconstitution, a pre-filled syringe with diluent, and needles. It emphasizes storing the product in the refrigerator at 2-8°C and specifies that it is for subcutaneous use only. The product is manufactured by Gland Pharma Limited in India. The provided information suggests a sterile product intended for medical use.*
FDA Label Image

Cetrorelix-spl-vial-label (Vial Label)

Cetrorelix-spl-vial-label (Vial Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.